Laura

🚨🚨How do we choose #antithrombotic regimen in pts w #AF & stable #CAD? Our SRMA of RCTs in @JACCJournals in collab w most trial PIs & a 🌟🌟group shows #anticoagulation alone ⬇️🩸 wo major risk. Great work @SinaRsh & 🙏🙏 team! @BrighamResearch 👇 jacc.org/doi/abs/10.101…

"Thrilled to share our new publication: Artificial Intelligence in Thrombosis: Transformative Potential and Emerging Challenges. Explore how AI is reshaping thrombosis care and the hurdles ahead. link.springer.com/article/10.118… #AI #Thrombosis #Research

Mañana empiezan las IX Jornadas Canarias de Hemostasia, un momento de encuentro de la Hematología Canaria para actualizarnos sobre trastornos de la hemostasia, trombosis, tratamiento antitrombótico y laboratorio. Avaladas por la @SETH__Oficial y la @sehh_es ¡Estamos listos!

Las IX Jornadas Canarias de Hemostasia darán comienzo mañana, organizadas por la Asociación Canaria de Hematología y Hemoterapia (#ACAHEM) y avaladas por la #SETH. 📆15 y 16 de noviembre 2024 📍Las Palmas de Gran Canaria ℹ️seth.es/formacion/ix-j… #formación #hemostasia #trombosis

La viñeta de hoy es para denunciar la campaña fascista contra la Cruz Roja: #FelizMiercoles #DanaValencia

Vitamin K2 for muscle cramps An RCT @JAMAInternalMed

Read this #lettertotheeditor from Shinya Yamada : Clarifying hyperfibrinolysis vs. enhanced-fibrinolytic DIC: Key markers (TAT, F1+2, PAP) are crucial for accurate diagnosis. Read more on distinguishing and managing these conditions rpthjournal.org/article/S2475-…

There was a great webinar on Afibrinogenemia this afternoon organised by the World Federation of Hemophilia. The session was recorded and will go on the @wfhemophilia website. If you are a patient, relative or doctor with patients with afibrinogenemia you will find it very informative.

1) Welcome to a 🆕accredited #tweetorial for 0.5hr CE/#CME from @cardiomet_ce. In this program our returning expert faculty @GBarnesMD from @umichCVC & @AnticoagForum discusses limitations of #DOACs and how emerging #anticoagulants may address them.

🩸 Protein C concentrate therapy for severe congenital protein C deficiency shows favorable outcomes. This review from Csaba Siffel summarizes 18 publications, highlighting varied regimens and successful treatment transitions from IV to subcutaneous. rpthjournal.org/article/S2475-…

FDA has licenced the anti -TFPI Marstacimab (Hympavzi) for Haemophilia A and B without inhibitors for aged 12 and older. ABR was 5.08 v 7.85 on previous prophylaxis- both high in my view

ÚLTIMA HORA: Una investigación de la ONU concluyó que Israel implementó una política concertada para destruir el sistema de salud de Gaza durante sus ataques, lo que constituye crímenes de guerra y el crimen de lesa humanidad de exterminio.

Online Now: The hallmarks of cancer immune evasion dlvr.it/TFFy1H

Calendario de dosificación perioperatoria de anticoagulantes orales directos (DOAC): JAMA 2024; DOI: 10.1001/jama.2024.12708

The Intelligence Age: ia.samaltman.com

“La vergüenza debe cambiar de bando”. Hoy declaro mi respeto inmenso a esta mujer: Gisèle Pelicot. Su marido la drogó durante años para que otros hombres la violaran estando inconsciente (más de 80 hombres acusados). No voy a calificar a estas bestias porque quiero centrarme en ella. Gisèle, con valentía y entereza, ha querido que el juicio se haga en público, que sea abierto, para que “se sepa todo” y “ninguna mujer sufra esta sumisión química”. Ella acude a las vistas con la cabeza alta y el rostro descubierto. Porque son “ellos” los que deben sentir vergüenza. Mi heroína de hoy. 💜

Rituximab refractory or intolerant immune TTP cases are very difficult to manage. Paper in @BrJHaem from France suggest that Daratumumab is a reasonable therapeutic option. tinyurl.com/59p7ybwt #TTP #daratumumab

This paper on thromboinflammation is everywhere this week. Unfortunately nobody commenting on it seems to have read it! I have, and it definitely doesn't say what commentators are suggesting. 🧵#Sec8" target="_blank" rel="nofollow noopener">nature.com/articles/s4158…

New #Review: Holme et al. discuss how emerging treatments for #haemophilia shift treatment goals from merely normalizing haemostasis to normalizing the life of persons with #haemophilia. Check out this thought-provoking article 👉buff.ly/3MeC4Xm #OpenAccess 🟢